The Seattle TimesSeattle Genetics has agreed to buy the Bristol-Myers Squibb manufacturing plant in Bothell for $43.3 million, giving the biotech the ability to make its own bulk quantities of antibodies for treating cancer. Until now the Bothell-based company has …Seattle Genetics buys Bristol-Myers Squibb drug manufacturing facility in BothellPuget Sound Business Journal (Seattle) all […]
from WordPress http://ift.tt/2vmwOup
via IFTTT
3 days ago
No comments:
Post a Comment